NTI 5.33% 7.1¢ neurotech international limited

Ann: Successful Completion of In Vitro Studies, page-2

  1. 2,574 Posts.
    lightbulb Created with Sketch. 4962
    Fantastic what a wonderful achievement! now let's look forward to some re-rating action.... this is really a great announcement for this company and for the sector in general..

    Screenshot_20201221_101257.jpg

    “These final trial results are very encouraging, in particular, the powerful anti-inflammatory mode of action of our strains compared to CBD alone,” said Brian Leedman, Chairman of Neurotech. These results demonstrate that the DOLCE/NTI leads may have a broader application in relation to the management and treatment of a number of neurological disorders”.

    Just WOW !

    Cheers

    Red bar
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
-0.004(5.33%)
Mkt cap ! $72.23M
Open High Low Value Volume
7.5¢ 7.5¢ 7.1¢ $41.31K 571.2K

Buyers (Bids)

No. Vol. Price($)
4 212673 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 76821 1
View Market Depth
Last trade - 14.01pm 16/08/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.